December 17, 2025
Alnylam Announces Major Expansion of U.S. Pharmaceutical Manufacturing Facility
$250 million investment will add new capacity and siRNA enzymatic ligation capabilities to Alnylam's Norton, Massachusetts site
Read More ›
December 8, 2025
The Future of Medicine is in Our Genes
Additional human genetics data partnerships are helping scientists identify new drug targets, improving the chances of developing effective medicines
Read More ›
December 3, 2025
11 Years, 11 Insights: What The Boston Globe Top Place to Work Survey Reveals About Our Su ...
We are extremely proud to be recognized once again as a Boston Globe Top Place to Work marking our 11th year in a row on the list.
Read More ›
November 18, 2025
Alnylam Challengers: Empowering Frontline Care for Underserved Communities in Boston
We are investing $2 million to advance the essential work of Boston’s frontline Care Navigators through Alnylam Challengers, our
Read More ›
October 24, 2025
Looking Beyond the Clinic: Putting Patients at the Center of Holistic Care in Transthyreti ...
Enhancing understanding of this life-threatening disease and ensuring that care reflects the realities of those living with it are vital goals shared across the
Read More ›
October 20, 2025
Alnylam’s Commitment to Health Literacy for All
As a patient-centric organization, Alnylam is fully committed to promoting the principles of health literacy as an integral part of our innovation and culture.
Read More ›
September 30, 2025
How Alnylam’s Manufacturing Investments Bring RNAi Therapeutics to More Patients, Faster
Translating our pioneering work in RNAi not only requires innovation in the lab - it requires innovation in how we make our medicines.
Read More ›
September 9, 2025
Five in A Row! Alnylam Named a 2025 Best Workplace for Innovators by Fast Company
We're proud to be named a Best Workplace for Innovators by Fast Company for the 5th year in a row.
Read More ›
August 26, 2025
RNAi Therapeutics: 5 Things You Should Know about this Innovative Class of Medicines
What is RNAi and what do RNAi therapeutics do? Here are 5 things you should know!
Read More ›
August 11, 2025
Everest and Everything In Between: A Journey Back to Nepal
One Alnylam employee's personal and spiritual journey home to Nepal and Everest to raise money for cancer research.
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site